Nano Precision Second Sight

Investor Relations

Please click on the logos for more information

Latest Presentation

2022 Investor Presentation

Latest Financial Results

Q2 2022

Quarter Ended June 30, 2022

Latest Annual Filing

For Fiscal Year Ending December 31, 2021

Company Profile

Vivani Medical, Inc. is a clinical stage company that develops implants that treat chronic diseases with high unmet medical need. Vivani represents the merger of Second Sight Medical Products, Inc. and NanoPrecision Medical, Inc. (NPM).

The Second Sight Division has developed, manufactured, and marketed implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, Second Sight is committed to developing new technologies to treat the broadest population of sight-impaired individuals.

The NPM Division is a near-clinical stage biopharmaceutical company focused on addressing drug non-adherence, a leading reason for poor outcomes in chronic diseases, with miniaturized long-term subdermal implants that are expected to address adherence for the life of the implant and thereby enable existing drugs to achieve their true potential.

Stock Snapshot

IR Contacts

Company

Vivani Medical, Inc.
5858 Horton Street #280
Emeryville, CA 94608
United States
T: 818-833-5000

Investor Relations

Brigid Makes
Chief Financial Officer
T: 818-833-5000
investors@vivani.com

Transfer Agent

Vstock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436